A Study That Looks at the Function of the Heart in Patients With Heart Failure Who Take Empagliflozin
Clinical trial NCT03332212 · COMPLETED
Trial details
- NCT number
- NCT03332212
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-01
- Primary completion
- 2020-05-21
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.